There’s a very interesting article by John Ioannidis in PLoS Medicine, the free online journal. Most current published research findings might well be false, he says. There are several factors, and I think it’s worth presenting them in detail:
1. Many research studies are small, with only a few dozen participants.
2. In many scientific fields, the “effect sizes” (a measure of how much a risk factor such as smoking increases a person’s risk of disease, or how much a treatment is likely to improve a disease) are small. Research findings are more likely true in scientific fields with large effects, such as the impact of smoking on cancer, than in scientific fields where postulated effects are small, such as genetic risk factors for diseases where many different genes are involved in causation. If the effect sizes are very small in a particular field, says Ioannidis, it is “likely to be plagued by almost ubiquitous false-positive claims.”
3. Financial and other interests and prejudices can also lead to untrue results.
4. “The hotter a scientific field (with more scientific teams involved), the less likely the research findings are to be true,” which may explain why we sometimes see “major excitement followed rapidly by severe disappointments in fields that draw wide attention.”
This ought to be an eye-opener…. The solution? More publication of preliminary findings, negative studies (which often suffer that fate of the file-drawer effect), confirmations, and refutations. PLoS says, “the editors encourage authors to discuss biases, study limitations, and potential confounding factors. We acknowledge that most studies published should be viewed as hypothesis-generating, rather than conclusive.” And maybe this will also temper journalists’ tendency to offer every new study as the Next Big Thing.
Embracing CX in the metaverse
More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.
Identity protection is key to metaverse innovation
As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.
The modern enterprise imaging and data value chain
For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.
Scientists have created synthetic mouse embryos with developed brains
The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.